Nutraceuticals as Potential Chemopreventive Agents: A Review
Journal:
The Natural Products Journal
Volume:
8
Page:
3-13
Author(s):
Vidhi J. Bhatia* and Sreeja S. Nair
Biologically Active Selenophenes and Benzo[b]selenophenes
Journal:
Current Organic Synthesis
Volume:
14
Page:
1091-1101
Author(s):
Ahmed B. Abdelwahab Mahmoud, Gilbert Kirsch* and Edgars Peagle
Research Progress on the Antitumor Effects of Rhein: Literature Review
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1624-1632
Author(s):
Chao Wu, Hongyan Cao, Hua Zhou, Lin Sun, Jingui Xue, Jianyuan Li, Yanqin Bian, Runfei Sun, Shu Dong, Ping Liu and Mingyu Sun*
Oncorine, the World First Oncolytic Virus Medicine and its Update in China
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
171-176
Author(s):
Min Liang*
Drug Delivery Nanoparticles in Treating Chemoresistant Tumor Cells
Journal:
Current Medicinal Chemistry
Volume:
24
Page:
4800-4815
Author(s):
Giuseppina Barrera, Martina Daga, Benedetta Ferrara, Chiara Dianzani, Stefania Pizzimenti, Monica Argenziano, Roberta Cavalli and Francesco Trotta*
Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
18
Page:
173-183
Author(s):
Voon Yee-Lin*, Wong Pooi-Fong and Alan Khoo Soo-Beng
Cytochrome P450 Structure, Function and Clinical Significance: A Review
Journal:
Current Drug Targets
Volume:
19
Page:
38-54
Author(s):
Palrasu Manikandan and Siddavaram Nagini*
Epigenetics of Virus-Induced Tumors: Perspectives for Therapeutic Targeting
Journal:
Current Pharmaceutical Design
Volume:
23
Page:
4842-4861
Author(s):
Svetlana Vinokurova*
Micro-RNA Profiling as a Predictor of Clinical Outcomes for Head and Neck Cancer Patients
Journal:
Current Pharmaceutical Design
Volume:
23
Page:
4729-4744
Author(s):
Tatyana Isayeva*, Margaret Brandwein-Gensler , Maheshika Somarathna , Lakisha D. Moore-Smith and Timmy Lee
Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation
Journal:
Current Cancer Drug Targets
Volume:
18
Page:
97-106
Author(s):
Samantha L. Martin, Rishabh Kala and Trygve O. Tollefsbol*